Proteomics Used in Identifying Novel Correlates of Disease in Pediatric Metabolic Dysfunction‐Associated Steatotic Liver Disease

Documenti analoghi

• GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes
  di: Gabriel Amorim Moreira Alves, et al.
  Pubblicazione: (2026)
• Linkage Between Hemoglobin to High Density Lipoprotein‐Cholesterol Ratio and Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationally Representative Study
  di: Zhiping Liu, et al.
  Pubblicazione: (2025)
• Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis
  di: Yovita Hartantri, et al.
  Pubblicazione: (2025)
• Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease
  di: Asier Erramuzpe, et al.
  Pubblicazione: (2025)
• Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
  di: Roxane Dilcher, et al.
  Pubblicazione: (2026)